Skip to main content

and
  1. No Access

    Chapter

    Physical Rationale for Proton Therapy and Elements to Build a Clinical Center

    In this chapter we present:

    1. The physical bases of proton therapy, going from microscopic concepts to macroscopic features

    A. Mazal, N. Fournier-Bidoz, F. Goudjil, S. Delacroix, C. Nauraye in Particle Radiotherapy (2016)

  2. No Access

    Article

    High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy

    We previously demonstrated that Busulfan–Thiotepa (Bu–Thio) and ASCT effectively treated patients with locally relapsed medulloblastoma after surgery and conventional chemotherapy. We thus evaluated the admini...

    D Valteau-Couanet, B Fillipini, E Benhamou, J Grill in Bone Marrow Transplantation (2005)

  3. Article

    Open Access

    Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases

    We analysed the clinical features and outcome of young patients with non-Ewing's flat bone sarcoma treated during the era of contemporary chemotherapy. The characteristics and outcome of 25 patients (15 males ...

    V Minard-Colin, C Kalifa, J-M Guinebretiere, L Brugieres in British Journal of Cancer (2004)

  4. Article

    Open Access

    Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy

    Standard treatment of optic pathways gliomas consists of radiotherapy and surgery when feasible. Owing to the toxicity of irradiation, chemotherapy has emerged as an interesting therapeutic option, especially ...

    E Lacaze, V Kieffer, A Streri, C Lorenzi, E Gentaz in British Journal of Cancer (2003)

  5. No Access

    Chapter and Conference Paper

    Patterns of Relapse Following Focal Irradiation of Intracranial Germinoma: Critical Review of TGM-TC90 SFOP protocol

    In the SFOP protocol TGM-TC90 for localised tumours, craniospinal (CS) prophylactic radiotherapy fields were replaced by carboplatin-based chemotherapy together with focal irradiation of the initial tumour vol...

    C. Alapetite, C. Carrie, H. Brisse, P. Thiesse, J-L. Habrand in Germ Cell Tumours V (2002)

  6. No Access

    Article

    Radiation therapy in the management of childhood brain tumors

    Radiation therapy (RT) still plays a major role in the management of intracranial malignancies, together with surgical resection and, more recently, chemotherapy. This is a review of the experience with fracti...

    J.-L. Habrand, Renaud De Crevoisier in Child's Nervous System (2001)

  7. No Access

    Article

    Clinical applications of proton therapy

    Proton therapy offers potentially considerable advantages in the management of slow-growing, poorly resectable or non-resectable tumors resistant to x-rays and located close to critical radiosensitive anatomic...

    J. L. Habrand, P. Schlienger, L. Schwartz in Radiation and Environmental Biophysics (1995)

  8. No Access

    Article

    New particles in radiotherapy: An introduction

    Since the discovery of x-rays and radioactivity, the radiotherapeutic management of malignancy has seen numerous spectacular improvements. Beside the widely used photons and electrons, one area of particular i...

    J. M. Cosset, M. Maher, J. L. Habrand in Radiation and Environmental Biophysics (1995)

  9. No Access

    Chapter

    Tumours of the Kidney

    This chapter discusses malignant tumours of the kidney; it therefore excludes the subject of benign renal tumours, which are principally cystic lesions and require surgery only when they are unilateral. The ma...

    M.-F. Tournade, J. Lemerle, J. L. Habrand, F. Gauthier, H. MacDowell in Cancer in Children (1992)

  10. No Access

    Article

    Brain tumours under the age of three. The price of survival

    Between 1975 and 1989, 98 children with brain tumours under the age of three at time of diagnosis were entered into a retrospective study. Twenty of them are alive and free of tumour more than five years after...

    E. Suc, C. Kalifa, R. Brauner, J. L. Habrand, M. J. Terrier-Lacombe in Acta Neurochirurgica (1990)

  11. No Access

    Article

    Enhanced cutaneous radiation effects following high-dose busulfan therapy

    Fifteen patients received irradiation after combined chemotherapy with high-dose busulfan followed by autologous or allogeneic bone marrow transplantation. Of nine patients irradiated between day 30 and day 70...

    G. Vassal, O. Hartmann, J. L. Habrand, J. L. Pico in Cancer Chemotherapy and Pharmacology (1989)